MAM
MGH Group to present CAPA India Aviation Summit 2024
Mumbai: Singapore Headquartered MGH Group, a diversified conglomerate with core investments in Pharma and FMCG Contract Logistics, Supply Chain Solutions, Ocean Carriers, and Airlines GSA representations, among others, is proud to announce its participation as the presenting sponsor at the CAPA India Aviation Summit 2024. This flagship aviation event is set to take place from 5 to 7 June in New Delhi, India, offering a unique platform for the international and Indian aviation community to connect, exchange ideas, and gain insights from industry leaders and experts.
MGH Group has established a formidable go-to-market presence and a strong foothold in Passenger, and Cargo segments boosting Route Profitability for Airlines through its extensive Global network and innovative solutions. The CAPA India Aviation Summit provides an excellent opportunity to showcase MGH’s achievements and future ambitions in the aviation sector.
MGH Group Global CEO Anis Ahmed expressed his enthusiasm for the upcoming summit. He stated, “We are thrilled to be the presenting sponsor at the CAPA India Aviation Summit 2024, underscoring our commitment to advancing the aviation industry through strategic partnerships and innovative solutions. This is a perfect platform to showcase our extensive network of relationships with freight forwarders, cargo aggregators, direct perishable exporters, ground handlers, and regulatory bodies across the USA, LATAM, Europe, Middle East, Africa, and Asia positions us uniquely to support and enhance global aviation logistics.”
The CAPA India Aviation Summit 2024 promises to be a landmark event, bringing together industry leaders, experts, and stakeholders to discuss the future of aviation in India and beyond. MGH Group’s participation in the CAPA India Aviation Summit reaffirms its dedication to fostering innovation and excellence in the aviation industry.
MAM
Beacon Group appoints Dr Rajesh Patel as Group CEO
36-year healthcare veteran to lead Beacon Diagnostics, Vector Biotek, Biogeny.
MUMBAI: A new chief, a fresh diagnosis and a sharper prescription for growth. Beacon Group has appointed Dr Rajesh Patel as its Group Chief Executive Officer, effective April 1, 2026, signalling a decisive push to scale its presence in the diagnostics and IVD space. Patel steps into the role with 36 years of experience across the healthcare and diagnostics industry, bringing a career shaped by leadership roles spanning sales, marketing, business development and operational strategy. His mandate is both expansive and precise: to steer the group’s overall strategic direction while tightening coordination across its three core entities Beacon Diagnostics, Vector Biotek and Biogeny Diagnostics.
In practical terms, that means driving cross-company synergies, accelerating market expansion and strengthening organisational capability areas increasingly critical as diagnostic players compete for scale in a fragmented yet rapidly evolving healthcare ecosystem. The group is positioning itself to capture unmet demand across chain laboratories, key accounts and standalone labs, segments that remain underserved despite growing diagnostic needs.
The appointment comes at a time when the In Vitro Diagnostics (IVD) sector in India is entering a more competitive and innovation-led phase, with companies focusing not just on product pipelines but also on service delivery, integration and customer-centric models. Beacon’s leadership appears to be betting that Patel’s execution-focused approach can help translate ambition into operational momentum.
Welcoming the appointment, Chairman Dr D K Joshi described Patel’s induction as a strategic move aligned with the group’s long-term vision, emphasising the role of leadership depth in navigating the next phase of growth.
For Beacon Group, the message is clear, in a sector where precision matters, leadership is the new differentiator—and this appointment is intended to set the tone for what comes next.
